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Stanford University, USA Alzheimer’s disease (AD) has been reported to show decreased metabolic activity in the
hippocampus using FDG PET-MR. Histological data suggests that the hippocampal
subfields are selectively affected in AD. Given the simultaneous imaging nature of inte-
grated PET-MR scanners and the multimodal capabilities of PET-MR, our purpose
here is to assess FDG activity, as well as ASL perfusion in the subfields of MCI and
AD patients. 10 consecutive subjects were recruited for this study 3 MCI, 3 AD
patients and 4 age-matched controls. The scanning was performed on a simultaneous
3T PET/MR scanner. To delineate the hippocampal subfields, automatic segmentation
of hippocampal subfields (ASHS) was employed. Static FDG-PET series were recon-
structed for analysis at 45-75 min for all subjects. All imaging sequences were automa-
tically registered to the oblique coronal T2-weighted images (segmentation space). PET
standardized uptake values (SUV) in the hippocampal subfields were normalized by the
pons. FDG PET metabolism was reduced significantly in AD, as well as MCI patients
as compared to controls, with the highest effect demonstrated in the CA3/DG and
CA1/2 (p = 0.047, subfields. Patients (MCI and AD combined) had decreased metabo-
lism as compared to controls in CA1/2 and significantly smaller volumes the Subicu-
lum. When assessing CBF across groups, a significant decrease in CBF was found in
the Subiculum. Our preliminary results demonstrate that PET-MRI may potentially be
a sensitive biomarker and tool for early diagnosis of AD. They also confirm the impor-
tance of assessing metabolic and structural changes of neurodegenerative diseases at
the subfield level.
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